188 related articles for article (PubMed ID: 22941752)
1. Detection and management of renal cell carcinoma in the renal allograft.
Végső G; Toronyi É; Deák PÁ; Doros A; Langer RM
Int Urol Nephrol; 2013 Feb; 45(1):93-8. PubMed ID: 22941752
[TBL] [Abstract][Full Text] [Related]
2. Renal cell carcinoma of the native kidney: a frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis.
Végsö G; Toronyi E; Hajdu M; Piros L; Görög D; Deák PA; Doros A; Péter A; Langer RM
Transplant Proc; 2011 May; 43(4):1261-3. PubMed ID: 21620106
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
[TBL] [Abstract][Full Text] [Related]
4. Management of renal masses in transplant allografts at an Australian kidney-pancreas transplant unit.
Su MZ; Campbell NA; Lau HM
Transplantation; 2014 Mar; 97(6):654-9. PubMed ID: 24212503
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous ultrasound-guided radiofrequency ablation of an allograft renal cell carcinoma: a case report.
Olivani A; Iaria M; Missale G; Capocasale E; Biasini E; Mazzoni MP; Lombardelli L; Luzi E; Frattini A; Pelosi G
Transplant Proc; 2011 Dec; 43(10):3997-9. PubMed ID: 22172886
[TBL] [Abstract][Full Text] [Related]
6. Regular ultrasound examination of transplanted kidneys allows early diagnosis of renal cell carcinoma and conservative nephron sparing surgery.
Lentini P; Granata A; Ciancio A; Gallieni M
Arch Ital Urol Androl; 2011 Dec; 83(4):195-9. PubMed ID: 22670317
[TBL] [Abstract][Full Text] [Related]
7. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
11. Partial nephrectomy used to treat renal cell carcinoma arising in a live donor transplant kidney.
Lamb GW; Baxter GM; Rodger RS; Aitchison M
Urol Res; 2004 May; 32(2):89-92. PubMed ID: 15250100
[TBL] [Abstract][Full Text] [Related]
12. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma from a transplanted allograft: two case reports and a review of the literature.
McHayleh W; Morcos JP; Wu T; Shapiro R; Yousem S; Appleman L; Friedland DM
Clin Genitourin Cancer; 2008 Mar; 6(1):53-5. PubMed ID: 18501084
[TBL] [Abstract][Full Text] [Related]
14. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency Ablation of T1a Renal Cell Carcinomas within Renal Transplant Allografts: Oncologic Outcomes and Graft Viability.
Cool DW; Kachura JR
J Vasc Interv Radiol; 2017 Dec; 28(12):1658-1663. PubMed ID: 28916346
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis.
Chang X; Liu T; Zhang F; Ji C; Zhao X; Wang W; Guo H
J Endourol; 2015 May; 29(5):518-25. PubMed ID: 25556579
[TBL] [Abstract][Full Text] [Related]
17. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation (RFA) of T1a renal cancer with externally cooled multitined expandable electrodes.
De Filippo M; Ziglioli F; Russo U; Pagano P; Brunese L; Bertelli E; Pagnini F; Maestroni U
Radiol Med; 2020 Aug; 125(8):790-797. PubMed ID: 32206984
[TBL] [Abstract][Full Text] [Related]
19. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
[TBL] [Abstract][Full Text] [Related]
20. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
